GlassScriptPhysician profile
Katelyn M Beggs
NPI 1215358064
$467.27
in general payments reported to CMS, 2019-2025
13 companies · $44.03 in 2025
The $44.03 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $125 · 2022: $146 · 2023: $49.72 · 2024: $102 · 2025: $44.03.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $196.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $195.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $143.76 | 2022-2025 | V-Loc 180 |
| Integra Lifesciences Corporation | $56.36 | 2021-2022 | |
| Baxter Healthcare | $42.21 | 2022 | |
| Trevena, INC. | $37.08 | 2021 | |
| Kerecis Limited | $31.25 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Kci USA, INC. | $30.74 | 2022-2023 | Prevena, Activ.A.C. |
| Solventum Corporation | $22.77 | 2024 | Prevena Restor Bellaform, Prevena, V.A.C. Veraflo Cleanse Choice |
| Smith+Nephew, INC. | $21.33 | 2023 | Oasis, Grafix Pl, Stravix |
| Takeda Pharmaceuticals U.S.A., INC. | $17.97 | 2021 | |
| Innocoll Pharmaceuticals Limited | $17.40 | 2021 | |
| Boston Scientific Corporation | $16.21 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.42 | 2021 | |
| Checkpoint Surgical, INC | $14.77 | 2024 | Checkpoint Stimulators |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katelyn Beggs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.